Skip to main content
logo
PolyNovo Limited (ASX:PNV)
Australia flag Australia · Delayed Price · Currency is AUD
1.265
-0.140 (-9.96%)
Oct 17, 2025, 4:10 PM AEST

PolyNovo Revenue

In the fiscal year ending June 30, 2025, PolyNovo had annual revenue of 128.7 million AUD with 24.67% growth. PolyNovo had revenue of 69.16 million in the half year ending June 30, 2025, with 90.62% growth.

Revenue
128.70M
Revenue Growth
+24.67%
P/S Ratio
6.79
Revenue / Employee
427.57K
Employees
301
Market Cap
873.92M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025128.70M25.47M24.67%
Jun 30, 2024103.23M37.56M57.20%
Jun 30, 202365.67M23.78M56.76%
Jun 30, 202241.89M12.55M42.78%
Jun 30, 202129.34M7.15M32.19%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Ramsay Health Care17.79B
Sonic Healthcare9.65B
Ansell3.06B
Cochlear2.34B
Regis Healthcare1.16B
Telix Pharmaceuticals1.01B
Neuren Pharmaceuticals218.86M
Revenue Rankings

PolyNovo News

More News